EMMAUS LIFE SCIENCES, INC. Chart calendar Emmaus Life Sciences, Inc.
d03abd84259.qsOfNtj-R7NTxwfsmKjVh0xiKM3aP7YJJuUEY1-va_Y.4qr5UpG_Kup-q2Wi8P3k2HUWcqS5b5s5Q5ROVRGYM7rzj81Yssd2hhWIaA~6e990861c6628c2ec50607961fae710a
Upcoming events on Emmaus Life Sciences, Inc.
Past events on Emmaus Life Sciences, Inc.
| 2024-05-09 | Q1 2024 Earnings Release (Projected) |
| 2023-11-14 09:30 | Q3 2023 Earnings Release |
| 2023-08-14 15:54 | Q2 2023 Earnings Release |
| 2023-05-15 09:30 | Q1 2023 Earnings Release |
| 2023-03-31 16:15 | Q4 2022 Earnings Release |
| 2022-12-08 17:00 | Annual General Meeting |
| 2022-11-14 18:17 | Q3 2022 Earnings Release |
| 2022-08-15 16:30 | Interim 2022 Earnings Release |
| 2022-06-23 12:30 | OTC Markets Group Zacks Virtual Life Sciences Investor Conference |
| 2022-05-24 07:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-13 08:23 | Q1 2022 Earnings Release |
| 2022-05-03 15:30 | Interim Investor Summit |
| 2022-04-02 | Meeting of the British Society for Haematology - E-Poster No.: BSH22- EP78 |
| 2022-03-31 17:24 | FY 2021 Earnings Release |
| 2022-01-10 07:00 | H.C. Wainwright BioConnect Conference |
| 2021-12-16 12:30 | OTC Markets Life Sciences Investor Forum |
| 2021-12-13 18:00 | American Society of Hematology Virtual Meeting and Exposition |
| 2021-11-22 | Annual General Meeting |
| 2021-11-16 14:00 | Investor Meeting |
| 2021-11-12 08:23 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 20,6 23,0 -10.39% | 18,4 18,6 -1.18% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -6,59 -5,40 -21.94% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
Net income Million USD | Released Forecast Spread | 1,10 | 0,00 0,00 - | 0,00 0,00 - |
|
EPS USD | Released Forecast Spread | 0,02 | 0,00 0,00 - | 0,00 0,00 - |
| Announcement Date | 04/05/21 | 31/03/22 | 31/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,02 6,63 -54.46% | 3,23 6,00 -46.1% | 4,29 6,00 -28.55% | 4,94 6,00 -17.68% | 5,93 7,00 -15.29% | 6,75 5,00 35.06% |
|
EBIT Million USD | Released Forecast Spread | -4,97 2,25 -320.96% | |||||
| Announcement Date | 31/03/22 | 13/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/05/23 |
More events
Past sector events for Emmaus Life Sciences, Inc.
| 2024-05-10 07:00 | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 16:10 | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | OMNIAB, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |